ESC 2019 - Results of the Phase 3 ORION-11 Trial

Published: 25 Sep 2019

  • Views:

    Views Icon 342
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating


Prof Kausik K Ray (Imperial College London, UK) discusses results of the resutls of the Phase 3 ORION-11 trial - Impact of inclisiran on LDL-C over 18 months in patients with ASCVD or risk-equivalent.


Filmed on site at ESC 2019 by Radcliffe Cardiology.

Videography:Dave Good & Doug George